Inventor
HACKAM DAVID J
US10 patents
⚠️ This page may combine multiple inventors who share the name “HACKAM DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION
5 patentsUS9562066B2Feb 7, 2017
Oral therapy of necrotizing enterocolitis
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION2 citations71
US9532999B2Jan 3, 2017
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION2 citations69
US10933077B2Mar 2, 2021
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations59
US10172848B2Jan 8, 2019
Gap junction-enhancing agents for treatment of necrotizing enterocolitis and inflammatory bowel disease
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations50
US10300083B2May 28, 2019
TLR4 inhibitors for the treatment of human infectious and inflammatory disorders
UNIV OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION0 citations48
HACKAM DAVID J
3 patentsUS8188058B2May 29, 2012
Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
HACKAM DAVID J53 citations92
US8518905B2Aug 27, 2013
Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment of prevention of toll-like receptor-4-associated disorders
HACKAM DAVID J15 citations87
US8518903B2Aug 27, 2013
Use of toll-like receptor-9 agonists
HACKAM DAVID J10 citations81